PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Lanzhou Yahua Biotechnology Ltd. Co, Lanzhou, China.\', \'Clinical Lab, Lanzhou Lung Hospital, Lanzhou, China.\', \'Clinical Lab, 940 Hospital of Joint Logistic Support, People\'s Liberation Army, Lanzhou, China.\', \'Lanzhou Yahua Biotechnology Ltd. Co, Lanzhou, China. shwjshzhx@163.com.\', \'Department of Medicine Biotechnology, Gansu Provincial Academic Institute for Medical Research, Lanzhou, China. shwjshzhx@163.com.\', \'Clinical Lab, Nanjing Gulou Hospital, Nanjing, China.\', \'Pathogeny Biology Lab, Gansu Disease Control and Prevention Center, Lanzhou, China.\', \'Department of Medicine Biotechnology, Gansu Provincial Academic Institute for Medical Research, Lanzhou, China.\', \'Institute of Infectious Disease, The 1st Hospital, Lanzhou University, Lanzhou, China.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1186/s12879-021-06568-9
?:hasPublicationType
?:journal
  • BMC infectious diseases
is ?:pmid of
?:pmid
?:pmid
  • 34425781
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.576
?:rankingScore_hIndex
  • 80
is ?:relation_isRelatedTo_publication of
?:title
  • Development and clinical evaluation of a rapid antibody lateral flow assay for the diagnosis of SARS-CoV-2 infection.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34425781>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34425781>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all